Should we routinely use mupirocin to prevent staphylococcal infections?

Virginia R. Roth, Cathryn Murphy, Trish M. Perl, Alfred DeMaria, Annette H. Sohn, Ronda L. Sinkowitz-Cochran, William R. Jarvis

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.

Original languageEnglish
Article number04423
Pages (from-to)745-749
Number of pages5
JournalInfection Control and Hospital Epidemiology
Volume21
Issue number11
DOIs
Publication statusPublished - 1 Jan 2000
Externally publishedYes

Fingerprint

Mupirocin
Staphylococcal Infections
Professional Practice
Cross Infection
Delivery of Health Care

Cite this

Roth, V. R., Murphy, C., Perl, T. M., DeMaria, A., Sohn, A. H., Sinkowitz-Cochran, R. L., & Jarvis, W. R. (2000). Should we routinely use mupirocin to prevent staphylococcal infections? Infection Control and Hospital Epidemiology, 21(11), 745-749. [04423]. https://doi.org/10.1086/501720
Roth, Virginia R. ; Murphy, Cathryn ; Perl, Trish M. ; DeMaria, Alfred ; Sohn, Annette H. ; Sinkowitz-Cochran, Ronda L. ; Jarvis, William R. / Should we routinely use mupirocin to prevent staphylococcal infections?. In: Infection Control and Hospital Epidemiology. 2000 ; Vol. 21, No. 11. pp. 745-749.
@article{f8c078e5cf754c8281f6384d599fa5d4,
title = "Should we routinely use mupirocin to prevent staphylococcal infections?",
abstract = "Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58{\%} indicated they would consider increased use of mupirocin.",
author = "Roth, {Virginia R.} and Cathryn Murphy and Perl, {Trish M.} and Alfred DeMaria and Sohn, {Annette H.} and Sinkowitz-Cochran, {Ronda L.} and Jarvis, {William R.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1086/501720",
language = "English",
volume = "21",
pages = "745--749",
journal = "Infection Control",
issn = "0899-823X",
publisher = "University of Chicago Press",
number = "11",

}

Roth, VR, Murphy, C, Perl, TM, DeMaria, A, Sohn, AH, Sinkowitz-Cochran, RL & Jarvis, WR 2000, 'Should we routinely use mupirocin to prevent staphylococcal infections?' Infection Control and Hospital Epidemiology, vol. 21, no. 11, 04423, pp. 745-749. https://doi.org/10.1086/501720

Should we routinely use mupirocin to prevent staphylococcal infections? / Roth, Virginia R.; Murphy, Cathryn; Perl, Trish M.; DeMaria, Alfred; Sohn, Annette H.; Sinkowitz-Cochran, Ronda L.; Jarvis, William R.

In: Infection Control and Hospital Epidemiology, Vol. 21, No. 11, 04423, 01.01.2000, p. 745-749.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Should we routinely use mupirocin to prevent staphylococcal infections?

AU - Roth, Virginia R.

AU - Murphy, Cathryn

AU - Perl, Trish M.

AU - DeMaria, Alfred

AU - Sohn, Annette H.

AU - Sinkowitz-Cochran, Ronda L.

AU - Jarvis, William R.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.

AB - Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.

UR - http://www.scopus.com/inward/record.url?scp=0033692834&partnerID=8YFLogxK

U2 - 10.1086/501720

DO - 10.1086/501720

M3 - Article

VL - 21

SP - 745

EP - 749

JO - Infection Control

JF - Infection Control

SN - 0899-823X

IS - 11

M1 - 04423

ER -

Roth VR, Murphy C, Perl TM, DeMaria A, Sohn AH, Sinkowitz-Cochran RL et al. Should we routinely use mupirocin to prevent staphylococcal infections? Infection Control and Hospital Epidemiology. 2000 Jan 1;21(11):745-749. 04423. https://doi.org/10.1086/501720